Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine

6 Jan 2016

Abstract excerpt

Personalized medicine is the science of individualized prevention and therapy. In the last decade, advances in high-throughput approaches allowed the development of proteomic and metabolomic studies in evaluating the association of genetic and phenotypic variability with disease sensitivity and analgesic response. These considerations have more value in case of multiple sclerosis (MuS), a multifactorial disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Multiple Sclerosis Research Studies
Share to Rheumatoid Arthritis Research and Therapies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27061322
DOI: 10.1002/prca.201500083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicinePMID 27061322Read ↗

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisSemantic proximity Read ↗

Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Semantic proximity Read ↗

Metabolomics in multiple sclerosisSemantic proximity Read ↗

Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.Semantic proximity Read ↗

Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosisSemantic proximity Read ↗

Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosisSemantic proximity Read ↗

Bioinformatics approach to identifying molecular biomarkers and networks in multiple sclerosisSemantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.Semantic proximity Read ↗

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read ↗

Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read ↗

Potential clinical biomarkers in rheumatoid arthritis with an omic approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.